Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Determining Disease Activity Biomarkers in Individuals With Takayasu`s Arteritis

Study:

VCRC Longitudinal Protocol for Takayasu`s Arteritis

Rationale:

n/a

Purpose:

Takayasu`s arteritis is a rare disorder that causes swelling and damage to the large arteries in the body, such as the aorta. In order to ensure proper treatment, measuring disease activity is critical. The purpose of this study is to establish new biological markers (biomarkers) to assess the severity of disease in people with Takayasu`s arteritis.

Study Status: Recruiting

Recruiting:
Katie Gartner 216-445-1397 gartnek@ccf.org

Condition Intervention Phase
Takayasu`s Arteritis n/a N/A

Verified by University of Pennsylvania November, 2013

Sponsored by: University of Pennsylvania
Information provided by: University of Pennsylvania
ClinicalTrials.gov identifier: NCT00315471

Study Type: Interventional

Study Design: Observational Model: Cohort, Time Perspective: Prospective

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Peter A. Merkel, MD, MPH., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site